Literature DB >> 26435644

West Nile virus IgM and IgG antibodies three years post- infection.

A Papa1, A Anastasiadou2, M Delianidou2.   

Abstract

BACKGROUND: West Nile virus (WNV) causes to humans a variety of symptoms, from asymptomatic infection to severe neuroinvasive disease. In a previous study, it was shown that WNV IgM antibodies persisted in three of 26 (12%) patients, nine months after onset of the symptoms. The aim of the present study was to test 10 of these patients, three years post-infection for probable persistence of IgM antibodies and to investigate their IgG antibody patterns.
MATERIAL AND METHODS: In summer 2013 serum samples were collected from 10 persons who were infected with WNV in 2010; 6 of them had a neuroinvasive disease. The three persons with detectable WNV IgM antibodies, nine months after onset of the symptoms, were included in the study. All samples were tested by ELISA in parallel with their stored paired samples taken in 2011. The positive results were confirmed by neutralization test.
RESULTS: WNV IgM antibodies were still detectable in the three persons, while high levels of WNV IgG and neutralizing antibodies were present in nine of the 10 persons, regardless the involvement of the nervous system.
CONCLUSIONS: WNV IgM antibodies persist for more than three years in 12% of patients with WNV infection, while WNV IgG antibodies persist and even increase their levels, regardless the involvement of the nervous system, suggesting that the immune response in the symptomatic WNV infections is strong and long-lasting. Hippokratia 2015, 19 (1): 34-36.

Entities:  

Keywords:  Greece; IgG antibodies; IgM antibodies; West Nile virus; persistence

Year:  2015        PMID: 26435644      PMCID: PMC4574583     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  19 in total

1.  Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs.

Authors:  A F Ochsenbein; D D Pinschewer; S Sierro; E Horvath; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals.

Authors:  Giuliana Cassese; Sergio Arce; Anja E Hauser; Katja Lehnert; Beate Moewes; Miro Mostarac; Gwendolin Muehlinghaus; Martin Szyska; Andreas Radbruch; Rudolf A Manz
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

3.  Persistence of West Nile virus immunoglobulin M antibodies, Greece.

Authors:  Anna Papa; Kostas Danis; Afroditi Athanasiadou; Maria Delianidou; Takis Panagiotopoulos
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

4.  Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.

Authors:  Imtiaz M Mumtaz; Bimba F Hoyer; Daniel Panne; Katrin Moser; Oliver Winter; Qingyu Y Cheng; Taketoshi Yoshida; Gerd-R Burmester; Andreas Radbruch; Rudolf A Manz; Falk Hiepe
Journal:  J Autoimmun       Date:  2012-06-20       Impact factor: 7.094

5.  Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.

Authors:  Harry E Prince; Mary Lapé-Nixon; Michael P Busch; Leslie H Tobler; Gregory A Foster; Susan L Stramer
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

6.  Excretion of West Nile virus in urine during acute infection.

Authors:  Luisa Barzon; Monia Pacenti; Elisa Franchin; Silvana Pagni; Thomas Martello; Margherita Cattai; Riccardo Cusinato; Giorgio Palù
Journal:  J Infect Dis       Date:  2013-07-02       Impact factor: 5.226

Review 7.  West Nile virus: review of the literature.

Authors:  Lyle R Petersen; Aaron C Brault; Roger S Nasci
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

8.  Persistence of West Nile virus-specific antibodies in viremic blood donors.

Authors:  Harry E Prince; Leslie H Tobler; Cindy Yeh; Nelly Gefter; Brian Custer; Michael P Busch
Journal:  Clin Vaccine Immunol       Date:  2007-07-25

9.  Neuromuscular manifestations of west nile virus infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic
Journal:  Front Neurol       Date:  2012-03-21       Impact factor: 4.003

10.  Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort.

Authors:  Melissa S Nolan; Amber S Podoll; Anne M Hause; Katherine M Akers; Kevin W Finkel; Kristy O Murray
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

View more
  5 in total

1.  Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Authors:  Judith A Anesi; Fernanda P Silveira
Journal:  Clin Transplant       Date:  2019-05-23       Impact factor: 2.863

2.  Duration of West Nile Virus Immunoglobulin M Antibodies up to 81 Months Following West Nile Virus Disease Onset.

Authors:  J Erin Staples; Katherine B Gibney; Amanda J Panella; Harry E Prince; Alison J Basile; Janeen Laven; James J Sejvar; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2022-04-11       Impact factor: 3.707

Review 3.  A 20-year historical review of West Nile virus since its initial emergence in North America: Has West Nile virus become a neglected tropical disease?

Authors:  Shannon E Ronca; Jeanne C Ruff; Kristy O Murray
Journal:  PLoS Negl Trop Dis       Date:  2021-05-06

4.  Seroprevalence Study on West Nile Virus (WNV) Infection, a Hidden Viral Disease in Fars Province, Southern Iran.

Authors:  Masoumeh Amin; Morteza Zaim; Hamideh Edalat; Hamid Reza Basseri; Mohammad Reza Yaghoobi-Ershadi; Farhad Rezaei; Kourosh Azizi; Mostafa Salehi-Vaziri; Mohsen Ghane; Saideh Yousefi; Sorna Dabaghmanesh; Sedigheh Kheirandish; Mohammad Esmaeil Najafi; Jalal Mohammadi
Journal:  J Arthropod Borne Dis       Date:  2020-06-30       Impact factor: 1.198

Review 5.  Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity.

Authors:  Yaniv Lustig; Danit Sofer; Efrat Dahan Bucris; Ella Mendelson
Journal:  Front Microbiol       Date:  2018-10-11       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.